AU3891299A - Combination therapy for treatment of depression - Google Patents

Combination therapy for treatment of depression

Info

Publication number
AU3891299A
AU3891299A AU38912/99A AU3891299A AU3891299A AU 3891299 A AU3891299 A AU 3891299A AU 38912/99 A AU38912/99 A AU 38912/99A AU 3891299 A AU3891299 A AU 3891299A AU 3891299 A AU3891299 A AU 3891299A
Authority
AU
Australia
Prior art keywords
depression
treatment
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38912/99A
Other languages
English (en)
Inventor
David . Michelson
Gary Dennis Tollefson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU3891299A publication Critical patent/AU3891299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU38912/99A 1998-05-21 1999-05-10 Combination therapy for treatment of depression Abandoned AU3891299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8626898P 1998-05-21 1998-05-21
US60086268 1998-05-21
PCT/US1999/010092 WO1999059593A1 (en) 1998-05-21 1999-05-10 Combination therapy for treatment of depression

Publications (1)

Publication Number Publication Date
AU3891299A true AU3891299A (en) 1999-12-06

Family

ID=22197424

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38912/99A Abandoned AU3891299A (en) 1998-05-21 1999-05-10 Combination therapy for treatment of depression

Country Status (5)

Country Link
EP (1) EP1077704A4 (de)
JP (1) JP2002515435A (de)
AU (1) AU3891299A (de)
CA (1) CA2332253A1 (de)
WO (1) WO1999059593A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US6174882B1 (en) * 1998-11-23 2001-01-16 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
GB2362826A (en) * 2000-06-02 2001-12-05 Lilly Co Eli A pharmaceutical composition comprising a serotonin transport inhibitor and a serotonin recptor antagonist
US20020107244A1 (en) * 2001-02-02 2002-08-08 Howard Harry R. Combination treatment for depression
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US6635675B2 (en) * 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
JPWO2004014429A1 (ja) * 2002-08-09 2005-12-02 三菱ウェルファーマ株式会社 精神疾患発症脆弱性制御剤
CA2503121A1 (en) 2002-10-25 2004-05-13 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US7704527B2 (en) 2002-10-25 2010-04-27 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
EP1723957A3 (de) 2002-12-27 2013-01-23 Otsuka Pharmaceutical Co., Ltd. Carbostyril-Derivate mit selektiven Serotonin-Aufnahme Inhibitoren, zur Behandlung von Gemütskrankheiten
CA2513893A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
FR2851163B1 (fr) * 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
EP1795196A3 (de) * 2003-04-04 2008-02-06 Dynogen Pharmaceuticals, Inc. Verfahren zur Behandlung von Erkrankungen der unteren Harnwege
CA2519379A1 (en) * 2003-04-04 2004-10-21 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
WO2005053703A1 (en) 2003-12-02 2005-06-16 Leslie James Sheldon Combination therapy for dementia, depression and apathy
JP2009503020A (ja) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 肥満症の治療におけるフリバンセリンの使用
EP1945214A1 (de) 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Benzimidazolon-derivate zur behandlung von prämenstruellen und anderen sexuellen störungen der frau
EP2037927B1 (de) 2006-06-30 2010-01-27 Boehringer Ingelheim International GmbH Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
CN101505736A (zh) 2006-08-25 2009-08-12 贝林格尔.英格海姆国际有限公司 控制释放系统及其制造方法
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973594A (en) * 1986-12-17 1990-11-27 Glaxo Group Limited Medicaments
AU8072691A (en) * 1990-06-28 1992-01-23 Beecham Group Plc Pharmaceutical preparations
US6211171B1 (en) * 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia

Also Published As

Publication number Publication date
CA2332253A1 (en) 1999-11-25
EP1077704A4 (de) 2002-01-30
WO1999059593A1 (en) 1999-11-25
EP1077704A1 (de) 2001-02-28
JP2002515435A (ja) 2002-05-28

Similar Documents

Publication Publication Date Title
AU3891299A (en) Combination therapy for treatment of depression
AU9028798A (en) Method of improving drug treatment
AU4411297A (en) Combination therapy for treatment of psychoses
AU4067697A (en) Therapeutic compositions for treatment of cancer
IL139592A0 (en) Combination therapy for treatment of refractory depression
AU3596199A (en) Treatment of celiac disease
AU3784999A (en) Methods for treatment of pain
AU3896900A (en) Treatment of pain
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
AU3760900A (en) Treatment of menstrual function
HUP0100365A3 (en) Combination therapy for the treatment of aids
AU1940800A (en) Combination therapy for the treatment of sepsis
AU2566201A (en) Compounds and methods for the treatment of pain
AU3988099A (en) Combination therapy for treating hypercholesterolemia
AU1405001A (en) Treatment of diseases
AU7545998A (en) Treatment of osteoporosis
AUPP229598A0 (en) Treatment of sunburn
AU5778399A (en) Gene therapy for treatment of cancer
AU6112299A (en) Treatment of effluents
AU2420201A (en) Compounds and methods for the treatment of pain
AU4406899A (en) Progesterone treatment of cancer
AU4475300A (en) Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression
AU4219799A (en) Combination therapy for treatment of fiv infection
PL346528A1 (en) Treatment of depression
AU2375297A (en) Treatment of hides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase